Occurrence of p53 Gene Deletions and Human Papilloma Virus Infection in Human Head and Neck Cancer

Cancer Research

Volumn 52, Issue 17, 1992, Pages 4832-4836

  Yandell, David ^c   Graves, Deborah ^a   Vokes, Everett ^a   Beckett, Michael ^a   Haraf, Daniel ^a   Dunphy, Edward ^a   Weichselbaum, Ralph R ^a  

^a Department of Radiation and Cellular Oncology ^*  (United States)

^b Departments of Social Medicine Medicine and Epidemiology   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MUTAGENIC AGENT; PROTEIN P53; VIRUS DNA;

ALCOHOL CONSUMPTION; ARTICLE; ESOPHAGUS CANCER; GENE DELETION; GENE SEQUENCE; GENETIC POLYMORPHISM; HEAD CANCER; HUMAN; HUMAN TISSUE; NECK CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WART VIRUS;

ALCOHOL DRINKING; BASE SEQUENCE; CHROMOSOME DELETION; DNA, VIRAL; GENES, P53; HEAD AND NECK NEOPLASMS; MUTATION; PAPILLOMAVIRUS; PLANTS, TOXIC; POLYMERASE CHAIN REACTION; SMOKING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TOBACCO; TUMOR VIRUS INFECTIONS;

EID: 0026737285     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Million, R. R., Cassisi, N. J., and Clark, J. R. Cancer of the head and neck. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.). Cancer Principles and Practice of Oncology, pp. 488-590. Philadelphia: J. B. Lippincott Company, 1989.
2. Pindborg, J. J. Control of oral cancer in developing countries. Bull. WHO, 62: 817-830, 1984.
3. Weinberg, R. A. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
4. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cav-anee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.), 355: 846-847, 1992.
5. Chiba, I., Takahashi, T., Nau, M. M., DAmico, D., Curiel, D. T., Mitsu-domi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S., Koga, H., Reiss-man, P. T., Slamon, D. J., Holmes, E. C., and Minna, J. D. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
6. Suzuki, H., Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y., Takahashi, T., and Ueda, R. p53 mutations in non-small cell lung cancer in Japan; association between mutations and smoking. Cancer Res., 52: 734-736, 1992.
7. Takahashi, T., Takahashi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6: 1775-1778, 1991.
8. Iggo, R., Gatter, K., Bartek, J., Lane, D., and Harris, A. L. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335: 675-679, 1990.
9. Hansel, C. H., Xiang, R. H., Sakaguchi, A. Y., and Naylor, S. L. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer. Oncogene, 6: 1067-1071, 1991.
10. Lehman, T. A., Bennett, W. P., Metcalf, R. A., Welsh, J. A., Ecker, J., Modali, R. V., Ullrich, S., Romano, J. W., Appella, E., Testa, J. R., Gerwin, B. L., and Harris, C. C. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res., 51: 4090-4096, 1991.
11. Hollstein, M. C., Peri, L., Mandard, A. M., Welsh, J. A., Montesano, R., Metcalf, R. A., Bak, M., and Harris, C. C. Genetic analysis of human esophageal tumors from two high incidence geographic areas: Frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51: 4102-4106, 1991.
12. Hollstein, M. C., Metcalf, R. A., Welsh, A., Montesano, R., and Harris, C. C. Frequent mutation of the p53 gene in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 887: 9958-9961, 1990.
13. Casson, A. G., Mukhopadhyay, T., Cleary, K. R., Ro, J. Y., Levin, B., and Roth, J. A. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 57:4495-4499, 1991.
14. Bennett, W. P., Hollstein, M. C., He, A., Zhu, S. M., Resau, J. H., Trump, B. F., Metcalf, R. A., Welsh, J. A., Midgley, C., Lane, D. P., and Harris, C. C. Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene, 6: 1779-1784, 1991.
15. zur Hausen, H. Viruses in human cancer. Science (Washington DC), 254: 1167-1173, 1991.
16. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C.p53 mutations in human cancers. Science (Washington DC), 253:49-53, 1991.
17. Weichselbaum, R. R., Rotmensch, J., Ahmed-Swan, S., and Beckett, M. A. Radiobiological characterization of 53 human tumor cell lines. Int. J. Radiat. Biol., 56: 553-560, 1989.
18. Mullis, K. B., Fallona, F. A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol., 155: 335-350.
19. Orita, M., Youichi, S., Seiya, T., and Hayashi, K. Rapid sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
20. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
21. Toguchida, J., Yamaguchi, T., Dayton, S. H., Beauchamp, R. L., Herrera, G. E., Kanji, L., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., Weichselbaum, R. R., and Yandell, D. W. Prevalence and spectrum of ger-mline mutations of the p53 gene among patients with sarcoma. N. Engl. J. Med., 326: 1301-1308, 1992.
22. McNicol, P. J., and Dodd, J. G. High prevalence of human papillomavirus in prostate tissues. J. Urol., 145: 850-853, 1991.
23. Manos, M. M., Ting, Y., Wright, D. K., et al. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells, 7: 209-214, 1989.
24. Lungu, O., Wright, T. C., Jr., and Silverstein, S. Typing of human papillomaviruses by polymerase chain reaction with LI consensus primers and RFLP analysis. Mol. Cell. Probes, in press, 1992.
25. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53:457-481, 1958.
26. Mantel, V. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
27. Mehta, C. R., and Patel, N. R. A network algorithm for performing Fisher's exact test in /? x C contingency tables. J. Am. Stat. Assoc., 78: 427-434, 1983.
28. Mehta, C. R., Patel, N. R., and Tsiatis, A. Exact significance testing to establish treatment equivalence for ordered categorical data. Biometrics, 40: 819-825, 1984.
29. Grosovsky, A. J., DeBoer, J. G., DeJong, P. J., Drobetsky, E. A., and Glick-man, B. W. Base substitutions, frameshifts, and small deletions constitute ionizing radiation-induced point mutations in mammalian cells. Proc. Natl. Acad. Sci. USA, 75: 185-188, 1988.
30. Waters, L. C., Sikpi M. O., Preston, J., Mitra, S., and Jaberaboansari, A. Mutations induced by ionizing radiation in a plasmid replicated in human cells. Radiat. Res., 127: 190-201, 1991.
31. Khanna, J. M., and Israel, Y. Ethanol metabolism. In: N. B. Javitt (ed.). Liver and Biliary Tract Physiology I (International Review of Physiology), pp. 275-315. Baltimore: University Park Press, 1980.
32. Ames, B. N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science (Washington DC), 221: 1256-1262, 1983.
33. Little, J. B., Radford, E. P., McCombs, H. L., and Hunt, V. R. Distribution of polonium210 in pulmonary tissues of cigarette smokers. N. Engl. J. Med., 273: 1343-1351, 1965.
34. Blot, W. J., McLaughin, J. K., Winn, D. M., Austin, D. F., Greenberg, R. S., Preston-Martin, S., Bernstein, L., Schoenberg, J. B., Stemhagen, A., and Fraumeni, J. F. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res., 48: 3282-3287, 1988.
35. Diller, L., Kassel, J., Nelson, C. E., Grka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772-5781, 1990.
36. Scheffner, M., Munger, K., Byrae, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 88: 5523-5527, 1991.
37. Riou, G., Favre, M., Jeannel, D., Bourhis, J., Le Doussal, V., and Orth, G. Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet, 335: 1171-1174, 1990.
38. Higgins, G. D., Davy, M., Roder, D., Uelin, D. M., Phillips, G. E., and Burrell, C. J. Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet, 338:910-913, 1991.
39. Brandama, J. L., and Abramson, A. L. Association of papillomavirus with cancers of the head and neck. Arch. Otolaryngol. Head Neck Surg., 115: 621-625, 1989.
40. Niedobitek, G., PitterofT, S., Herbst, H., Shepherd, P., Finn, T., Anagnosto-poulos. I., and Stein, H. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J. Clin. Pathol., 43:913-921, 1990.
41. Brachman, D. G., Hallahan, D. E., Beckett, M. A., Yandell, D. W., and Weichselbaum, R. R. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Res., 51: 6393-6396, 1991.
42. Gusterson, B. A., Anbazhagan, R., Warren, W., Midgely, C., Lane, D. P., O'Hare, M., Stamps, A., Carter, R., and Jayatilake, H., Expression of p53 in premalignant and malignant squamous epithelium. Oncogene, 6:1785-1789, 1991.
43. Field, J. K., Spandidos, D. A., Malliri, A., Gosney, J. R., Yiagnisis, M., and Stell, P. M. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br. J. Cancer, 64: 573-577.
44. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K. V., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.